Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
Identifieur interne : 003035 ( Main/Exploration ); précédent : 003034; suivant : 003036Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
Auteurs : Jane A. Cannon [Royaume-Uni] ; Timothy J. Collier [Royaume-Uni] ; Li Shen [Royaume-Uni] ; Karl Swedberg [Suède] ; Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; John Vincent [États-Unis] ; Stuart J. Pocock [Royaume-Uni] ; Bertram Pitt [États-Unis] ; Faiez Zannad [France] ; John J V. Mcmurray [Royaume-Uni]Source :
- European journal of heart failure [ 1879-0844 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antagonistes des récepteurs des minéralocorticoïdes (usage thérapeutique), Attribution aléatoire, Débit systolique (physiologie), Défaillance cardiaque (mortalité), Défaillance cardiaque (physiopathologie), Défaillance cardiaque (traitement médicamenteux), Femelle, Hospitalisation (), Humains, Mâle, Méthode en double aveugle, Résultat thérapeutique, Spironolactone (analogues et dérivés), Spironolactone (usage thérapeutique), Sujet âgé, Taux de survie, Électrocardiographie.
- MESH :
- analogues et dérivés : Spironolactone.
- mortalité : Défaillance cardiaque.
- physiologie : Débit systolique.
- physiopathologie : Défaillance cardiaque.
- traitement médicamenteux : Défaillance cardiaque.
- usage thérapeutique : Antagonistes des récepteurs des minéralocorticoïdes, Spironolactone.
- Adulte d'âge moyen, Attribution aléatoire, Femelle, Hospitalisation, Humains, Mâle, Méthode en double aveugle, Résultat thérapeutique, Sujet âgé, Taux de survie, Électrocardiographie.
English descriptors
- KwdEn :
- Aged, Double-Blind Method, Electrocardiography, Female, Heart Failure (drug therapy), Heart Failure (mortality), Heart Failure (physiopathology), Hospitalization (statistics & numerical data), Humans, Male, Middle Aged, Mineralocorticoid Receptor Antagonists (therapeutic use), Random Allocation, Spironolactone (analogs & derivatives), Spironolactone (therapeutic use), Stroke Volume (physiology), Survival Rate, Treatment Outcome.
- MESH :
- chemical , analogs & derivatives : Spironolactone.
- chemical , therapeutic use : Mineralocorticoid Receptor Antagonists, Spironolactone.
- drug therapy : Heart Failure.
- mortality : Heart Failure.
- physiology : Stroke Volume.
- physiopathology : Heart Failure.
- statistics & numerical data : Hospitalization.
- Aged, Double-Blind Method, Electrocardiography, Female, Humans, Male, Middle Aged, Random Allocation, Survival Rate, Treatment Outcome.
Abstract
We examined the relationship between different degrees of QRS prolongation and different QRS morphologies and clinical outcomes in patients with heart failure, reduced ejection fraction (HF-REF), and mild symptoms in the Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure trial (EMPHASIS-HF). We also evaluated the effect of eplerenone in these patients according to QRS duration/morphology.
DOI: 10.1002/ejhf.303
PubMed: 26139584
Affiliations:
- Australie, France, Pays-Bas, Royaume-Uni, Suède, États-Unis
- Angleterre, Grand Est, Grand Londres, Lorraine (région), Michigan, Victoria (État), Écosse, État de New York
- Glasgow, Londres, Melbourne, Nancy
- Nancy-Université, Université de Glasgow
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B96
- to stream PubMed, to step Curation: 002B23
- to stream PubMed, to step Checkpoint: 002B23
- to stream Ncbi, to step Merge: 002802
- to stream Ncbi, to step Curation: 002802
- to stream Ncbi, to step Checkpoint: 002802
- to stream Main, to step Merge: 003036
- to stream Main, to step Curation: 003035
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).</title><author><name sortKey="Cannon, Jane A" sort="Cannon, Jane A" uniqKey="Cannon J" first="Jane A" last="Cannon">Jane A. Cannon</name><affiliation wicri:level="4"><nlm:affiliation>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Collier, Timothy J" sort="Collier, Timothy J" uniqKey="Collier T" first="Timothy J" last="Collier">Timothy J. Collier</name><affiliation wicri:level="3"><nlm:affiliation>London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>London School of Hygiene & Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Shen, Li" sort="Shen, Li" uniqKey="Shen L" first="Li" last="Shen">Li Shen</name><affiliation wicri:level="4"><nlm:affiliation>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Swedberg, Karl" sort="Swedberg, Karl" uniqKey="Swedberg K" first="Karl" last="Swedberg">Karl Swedberg</name><affiliation wicri:level="1"><nlm:affiliation>University of Gothenburg, Gothenburg, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>University of Gothenburg, Gothenburg</wicri:regionArea><wicri:noRegion>Gothenburg</wicri:noRegion></affiliation></author><author><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name><affiliation wicri:level="3"><nlm:affiliation>Monash University, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Monash University, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name><affiliation wicri:level="1"><nlm:affiliation>University Medical Centre Groningen, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Medical Centre Groningen</wicri:regionArea></affiliation></author><author><name sortKey="Vincent, John" sort="Vincent, John" uniqKey="Vincent J" first="John" last="Vincent">John Vincent</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Pharma, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Pharma, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Pocock, Stuart J" sort="Pocock, Stuart J" uniqKey="Pocock S" first="Stuart J" last="Pocock">Stuart J. Pocock</name><affiliation wicri:level="3"><nlm:affiliation>London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>London School of Hygiene & Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Pitt, Bertram" sort="Pitt, Bertram" uniqKey="Pitt B" first="Bertram" last="Pitt">Bertram Pitt</name><affiliation wicri:level="2"><nlm:affiliation>University of Michigan, MI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Michigan, MI</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name><affiliation wicri:level="4"><nlm:affiliation>Nancy Université, Nancy, France Inserm, Université de Lorraine and CHU de Nancy, Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nancy Université, Nancy, France Inserm, Université de Lorraine and CHU de Nancy, Nancy</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Lorraine (région)</region><settlement type="city">Nancy</settlement><settlement type="city">Nancy</settlement></placeName><orgName type="university">Nancy-Université</orgName></affiliation></author><author><name sortKey="Mcmurray, John J V" sort="Mcmurray, John J V" uniqKey="Mcmurray J" first="John J V" last="Mcmurray">John J V. Mcmurray</name><affiliation wicri:level="4"><nlm:affiliation>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26139584</idno><idno type="pmid">26139584</idno><idno type="doi">10.1002/ejhf.303</idno><idno type="wicri:Area/PubMed/Corpus">002B96</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B96</idno><idno type="wicri:Area/PubMed/Curation">002B23</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B23</idno><idno type="wicri:Area/PubMed/Checkpoint">002B23</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002B23</idno><idno type="wicri:Area/Ncbi/Merge">002802</idno><idno type="wicri:Area/Ncbi/Curation">002802</idno><idno type="wicri:Area/Ncbi/Checkpoint">002802</idno><idno type="wicri:Area/Main/Merge">003036</idno><idno type="wicri:Area/Main/Curation">003035</idno><idno type="wicri:Area/Main/Exploration">003035</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).</title><author><name sortKey="Cannon, Jane A" sort="Cannon, Jane A" uniqKey="Cannon J" first="Jane A" last="Cannon">Jane A. Cannon</name><affiliation wicri:level="4"><nlm:affiliation>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Collier, Timothy J" sort="Collier, Timothy J" uniqKey="Collier T" first="Timothy J" last="Collier">Timothy J. Collier</name><affiliation wicri:level="3"><nlm:affiliation>London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>London School of Hygiene & Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Shen, Li" sort="Shen, Li" uniqKey="Shen L" first="Li" last="Shen">Li Shen</name><affiliation wicri:level="4"><nlm:affiliation>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author><author><name sortKey="Swedberg, Karl" sort="Swedberg, Karl" uniqKey="Swedberg K" first="Karl" last="Swedberg">Karl Swedberg</name><affiliation wicri:level="1"><nlm:affiliation>University of Gothenburg, Gothenburg, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>University of Gothenburg, Gothenburg</wicri:regionArea><wicri:noRegion>Gothenburg</wicri:noRegion></affiliation></author><author><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name><affiliation wicri:level="3"><nlm:affiliation>Monash University, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Monash University, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name><affiliation wicri:level="1"><nlm:affiliation>University Medical Centre Groningen, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Medical Centre Groningen</wicri:regionArea></affiliation></author><author><name sortKey="Vincent, John" sort="Vincent, John" uniqKey="Vincent J" first="John" last="Vincent">John Vincent</name><affiliation wicri:level="2"><nlm:affiliation>Pfizer Pharma, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Pfizer Pharma, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Pocock, Stuart J" sort="Pocock, Stuart J" uniqKey="Pocock S" first="Stuart J" last="Pocock">Stuart J. Pocock</name><affiliation wicri:level="3"><nlm:affiliation>London School of Hygiene & Tropical Medicine, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>London School of Hygiene & Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Pitt, Bertram" sort="Pitt, Bertram" uniqKey="Pitt B" first="Bertram" last="Pitt">Bertram Pitt</name><affiliation wicri:level="2"><nlm:affiliation>University of Michigan, MI, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Michigan, MI</wicri:regionArea><placeName><region type="state">Michigan</region></placeName></affiliation></author><author><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name><affiliation wicri:level="4"><nlm:affiliation>Nancy Université, Nancy, France Inserm, Université de Lorraine and CHU de Nancy, Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nancy Université, Nancy, France Inserm, Université de Lorraine and CHU de Nancy, Nancy</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Lorraine (région)</region><settlement type="city">Nancy</settlement><settlement type="city">Nancy</settlement></placeName><orgName type="university">Nancy-Université</orgName></affiliation></author><author><name sortKey="Mcmurray, John J V" sort="Mcmurray, John J V" uniqKey="Mcmurray J" first="John J V" last="Mcmurray">John J V. Mcmurray</name><affiliation wicri:level="4"><nlm:affiliation>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>BHF Cardiovascular Research Centre, University of Glasgow, Glasgow</wicri:regionArea><orgName type="university">Université de Glasgow</orgName><placeName><settlement type="city">Glasgow</settlement><region type="country">Écosse</region></placeName></affiliation></author></analytic><series><title level="j">European journal of heart failure</title><idno type="eISSN">1879-0844</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Double-Blind Method</term><term>Electrocardiography</term><term>Female</term><term>Heart Failure (drug therapy)</term><term>Heart Failure (mortality)</term><term>Heart Failure (physiopathology)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Mineralocorticoid Receptor Antagonists (therapeutic use)</term><term>Random Allocation</term><term>Spironolactone (analogs & derivatives)</term><term>Spironolactone (therapeutic use)</term><term>Stroke Volume (physiology)</term><term>Survival Rate</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antagonistes des récepteurs des minéralocorticoïdes (usage thérapeutique)</term><term>Attribution aléatoire</term><term>Débit systolique (physiologie)</term><term>Défaillance cardiaque (mortalité)</term><term>Défaillance cardiaque (physiopathologie)</term><term>Défaillance cardiaque (traitement médicamenteux)</term><term>Femelle</term><term>Hospitalisation ()</term><term>Humains</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Résultat thérapeutique</term><term>Spironolactone (analogues et dérivés)</term><term>Spironolactone (usage thérapeutique)</term><term>Sujet âgé</term><term>Taux de survie</term><term>Électrocardiographie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Spironolactone</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Mineralocorticoid Receptor Antagonists</term><term>Spironolactone</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Spironolactone</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Débit systolique</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stroke Volume</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes des récepteurs des minéralocorticoïdes</term><term>Spironolactone</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Double-Blind Method</term><term>Electrocardiography</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Random Allocation</term><term>Survival Rate</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Attribution aléatoire</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Mâle</term><term>Méthode en double aveugle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Taux de survie</term><term>Électrocardiographie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We examined the relationship between different degrees of QRS prolongation and different QRS morphologies and clinical outcomes in patients with heart failure, reduced ejection fraction (HF-REF), and mild symptoms in the Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure trial (EMPHASIS-HF). We also evaluated the effect of eplerenone in these patients according to QRS duration/morphology.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Pays-Bas</li><li>Royaume-Uni</li><li>Suède</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Grand Est</li><li>Grand Londres</li><li>Lorraine (région)</li><li>Michigan</li><li>Victoria (État)</li><li>Écosse</li><li>État de New York</li></region><settlement><li>Glasgow</li><li>Londres</li><li>Melbourne</li><li>Nancy</li></settlement><orgName><li>Nancy-Université</li><li>Université de Glasgow</li></orgName></list><tree><country name="Royaume-Uni"><region name="Écosse"><name sortKey="Cannon, Jane A" sort="Cannon, Jane A" uniqKey="Cannon J" first="Jane A" last="Cannon">Jane A. Cannon</name></region><name sortKey="Collier, Timothy J" sort="Collier, Timothy J" uniqKey="Collier T" first="Timothy J" last="Collier">Timothy J. Collier</name><name sortKey="Mcmurray, John J V" sort="Mcmurray, John J V" uniqKey="Mcmurray J" first="John J V" last="Mcmurray">John J V. Mcmurray</name><name sortKey="Pocock, Stuart J" sort="Pocock, Stuart J" uniqKey="Pocock S" first="Stuart J" last="Pocock">Stuart J. Pocock</name><name sortKey="Shen, Li" sort="Shen, Li" uniqKey="Shen L" first="Li" last="Shen">Li Shen</name></country><country name="Suède"><noRegion><name sortKey="Swedberg, Karl" sort="Swedberg, Karl" uniqKey="Swedberg K" first="Karl" last="Swedberg">Karl Swedberg</name></noRegion></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name></region></country><country name="Pays-Bas"><noRegion><name sortKey="Van Veldhuisen, Dirk J" sort="Van Veldhuisen, Dirk J" uniqKey="Van Veldhuisen D" first="Dirk J" last="Van Veldhuisen">Dirk J. Van Veldhuisen</name></noRegion></country><country name="États-Unis"><region name="État de New York"><name sortKey="Vincent, John" sort="Vincent, John" uniqKey="Vincent J" first="John" last="Vincent">John Vincent</name></region><name sortKey="Pitt, Bertram" sort="Pitt, Bertram" uniqKey="Pitt B" first="Bertram" last="Pitt">Bertram Pitt</name></country><country name="France"><region name="Grand Est"><name sortKey="Zannad, Faiez" sort="Zannad, Faiez" uniqKey="Zannad F" first="Faiez" last="Zannad">Faiez Zannad</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003035 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003035 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26139584
|texte= Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26139584" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |